Association between Class III Obesity (BMI of 40–59 kg/m2) and Mortality: A Pooled Analysis of 20 Prospective Studies

Summary

Background The prevalence of class III obesity (body mass index [BMI]≥40 kg/m2) has increased dramatically in several countries and currently affects 6% of adults in the US, with uncertain impact on the risks of illness and death. Using data from a large pooled study, we evaluated the risk of death, overall and due to a wide range of causes, and years of life expectancy lost associated with class III obesity. Methods and Findings In a pooled analysis of 20 prospective studies from the United States, Sweden, and Australia, we estimated sex- and age-adjusted total and cause-specific mortality rates (deaths per 100,000 persons per year) and multivariable-adjusted hazard ratios for adults, aged 19–83 y at baseline, classified as obese class III (BMI 40.0–59.9 kg/m2) compared with those classified as normal weight (BMI 18.5–24.9 kg/m2). Participants reporting ever smoking cigarettes or a history of chronic disease (heart disease, cancer, stroke, or emphysema) on baseline questionnaires were excluded. Among 9,564 class III obesity participants, mortality rates were 856.0 in men and 663.0 in women during the study period (1976–2009). Among 304,011 normal-weight participants, rates were 346.7 and 280.5 in men and women, respectively. Deaths from heart disease contributed largely to the excess rates in the class III obesity group (rate differences = 238.9 and 132.8 in men and women, respectively), followed by deaths from cancer (rate differences = 36.7 and 62.3 in men and women, respectively) and diabetes (rate differences = 51.2 and 29.2 in men and women, respectively). Within the class III obesity range, multivariable-adjusted hazard ratios for total deaths and deaths due to heart disease, cancer, diabetes, nephritis/nephrotic syndrome/nephrosis, chronic lower respiratory disease, and influenza/pneumonia increased with increasing BMI. Compared with normal-weight BMI, a BMI of 40–44.9, 45–49.9, 50–54.9, and 55–59.9 kg/m2 was associated with an estimated 6.5 (95% CI: 5.7–7.3), 8.9 (95% CI: 7.4–10.4), 9.8 (95% CI: 7.4–12.2), and 13.7 (95% CI: 10.5–16.9) y of life lost. A limitation was that BMI was mainly ascertained by self-report. Conclusions Class III obesity is associated with substantially elevated rates of total mortality, with most of the excess deaths due to heart disease, cancer, and diabetes, and major reductions in life expectancy compared with normal weight.

Related articles

• Why the future of healthcare lies in a digital world

  The document discusses the transformative impact of digital healthcare technologies, particularly in the context of the COVID-19 pandemic, and emphasizes the necessity for healthcare professionals to adapt to these changes for future success.

• Embryology: Veterinary Fertilization Processes

  This document provides an extensive overview of embryology in veterinary science, detailing the processes of fertilization, including mating, artificial insemination, and in vitro fertilization techniques. It covers the biological mechanisms and practical applications of reproductive technologies in animals.

• Multicenter, Randomized, Phase III Trial of Short-Term Radiotherapy Plus Chemotherapy Versus Long-Term Chemoradiotherapy in Locally Advanced Rectal Cancer (STELLAR)

  This study assesses the efficacy of preoperative short-term radiotherapy followed by chemotherapy compared to standard long-term chemoradiotherapy in patients with locally advanced rectal cancer, evaluating outcomes such as disease-free survival and treatment toxicity.

• Kappa Free Light Chain Index in the Diagnosis of Multiple Sclerosis

  This document discusses the adoption of the kappa free light chain (KFLC) index as a diagnostic tool for multiple sclerosis (MS), detailing its role alongside MRI and expert assessments to enhance diagnostic accuracy and reduce latency.

• Diagnostic Performance of Red Blood Cell Indices in the Differential Diagnosis of Iron Deficiency Anemia and the Thalassemia Trait in Chile: A Retrospective Study

  This retrospective study evaluates the diagnostic performance of 29 red blood cell indices in differentiating between iron deficiency anemia and the thalassemia trait in Chile, analyzing CBC results from 182 patients.